Yan Moore - 07 Feb 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Medical Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Yan Moore
Issuer symbol
OMGAQ
Transactions as of
07 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 16:59:27 UTC
Previous filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +110,000 $0.000000 110,000 07 Feb 2024 Common Stock 110,000 $3.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.